CLX vs PTCT · P/E 15, rev $7.10B vs rev $633.1M
The Clorox Company (CLX) versus PTC Therapeutics Inc (PTCT) — a side-by-side from cached financials, not a winner call.
The Clorox Company (CLX) is a household & personal products company listed on US.
PTC Therapeutics Inc (PTCT) is a biotechnology company listed on NASDAQ.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
Latest reported PTCT revenue for 2026-06-30 was $633.1M. Net income was $80.7M. PTCT currently screens at market cap $6.51B.
CLX currently screens at market cap $10.89B and trailing P/E 14.6. PTCT currently screens at market cap $6.51B.
Not investment advice. Open the CLX and PTCT stock pages for the full models.
Not investment advice.